Institute Of Oncology Ljubljana

This study is testing a special type of ultrasound called elastography to help surgeons make better decisions during breast cancer operations. It focuses on patients who had chemotherapy before surgery and aims to see if this scan can accurately tell if cancer remains in the lymp…

This study tests a personalized, non-hormonal approach to relieve uncomfortable menopause symptoms like vaginal dryness and pain during sex in women who have finished cancer treatment. Researchers will compare two groups of 65 participants to see if tailored treatments improve th…

This study aims to understand how a local treatment called electrochemotherapy changes the area around melanoma skin tumors. Researchers will study tissue samples from about 10-15 patients before and after treatment to see if it makes the tumors more visible to the immune system.…

This study aims to understand how a person's mental outlook and coping ability affect their quality of life during and after radiation treatment for prostate cancer. Researchers will follow 250 men for one year, asking them to complete questionnaires about their health and well-b…

This study aims to find early warning signs that predict if breast cancer will spread to the brain and spinal cord. Researchers are analyzing old tumor tissue and blood samples from 22 women who were treated for early-stage breast cancer. The goal is to identify markers that coul…

This study aims to find biological markers that can predict which early breast cancer patients will respond well to chemotherapy given before surgery. Researchers will analyze tumor tissue and blood samples from 268 patients to look for immune system signals and cancer fragments …

This study aims to find better ways to predict how throat cancer responds to standard chemo-radiation treatment. Researchers will test blood samples and special MRI scans in 30 patients to identify markers that show whether treatment is working. The goal is to help doctors make b…

This study aims to understand if the types of bacteria in a person's gut can predict how well they will respond to immunotherapy for advanced melanoma. Researchers enrolled 150 patients to collect stool and blood samples before and during their standard treatment. The goal is to …